Bone Regeneration in Defects Compromised by Radiotherapy

Abstract

Because bone reconstruction in irradiated sites is less than ideal, we applied a regenerative gene therapy method in which a cell-signaling virus was localized to biomaterial scaffolds to regenerate wounds compromised by radiation therapy. Critical-sized defects were created in rat calvariae previously treated with radiation. Gelatin scaffolds containing lyophilized adenovirus encoding BMP-2 (AdBMP-2) or freely suspended AdBMP-2 were transplanted. Lyophilized AdBMP-2 significantly improved bone quality and quantity over free AdBMP-2. Bone mineral density was reduced after radiotherapy. Histological analyses demonstrated that radiation damage led to less bone regeneration. The woven bone and immature marrow formed in the radiated defects indicated that irradiation retarded normal bone development. Finally, we stored the scaffolds with lyophilized AdBMP-2 at −80°C to determine adenovirus stability. Micro-CT quantification demonstrated no significant differences between bone regeneration treated with lyophilized AdBMP-2 before and after storage, suggesting that virus-loaded scaffolds may be convenient for application as pre-made constructs.

Get full access to this article

View all access options for this article.

References

Chang SC, Wei FC, Chuang HL, Chen YR, Chen JK, Lee KC, et al. (2003). Ex vivo gene therapy in autologous critical-size craniofacial bone regeneration. Plast Reconstr Surg 112:1841–1850.

Deutsch M, Kroll SS, Ainsle N, Wang B (1999). Influence of radiation on late complications in patients with free fibular flaps for mandibular reconstruction. Ann Plast Surg 42:662–664.

Disa JJ, Cordeiro PG (2000). Mandible reconstruction with microvascular surgery. Semin Surg Oncol 19:226–234.

Ehrhart NP, Hong L, Morgan AL, Eurell JA, Jamison RD (2005). Effect of transforming growth factor-beta1 on bone regeneration in critical-sized bone defects after irradiation of host tissues. Am J Vet Res 66:1039–1045.

Emerick KS, Teknos TN (2007). State-of-the-art mandible reconstruction using revascularized free-tissue transfer. Expert Rev Anticancer Ther 7:1781–1788.

Fields MT, Eisbruch A, Normolle D, Orfali A, Davis MA, Pu AT, et al. (2000). Radiosensitization produced in vivo by once- vs. twice-weekly 2′2′-difluoro-2′-deoxycytidine (gemcitabine). Int J Radiat Oncol Biol Phys 47:785–791.

Franceschi RT (2005). Biological approaches to bone regeneration by gene therapy. J Dent Res 84:1093–1103.

Gysin R, Wergedal JE, Sheng MH, Kasukawa Y, Miyakoshi N, Chen ST, et al. (2002). Ex vivo gene therapy with stromal cells transduced with a retroviral vector containing the BMP4 gene completely heals critical size calvarial defect in rats. Gene Ther 9:991–999.

Hardy S, Kitamura M, Harris-Stansil T, Dai Y, Phipps ML (1997). Construction of adenovirus vectors through Cre-lox recombination. J Virol 71:1842–1849.

10.

Howard BK, Brown KR, Leach JL, Chang CH, Rosenthal DI (1998). Osteoinduction using bone morphogenic protein in irradiated tissue. Arch Otolaryngol Head Neck Surg 124:985–988.

11.

Hu WW, Wang Z, Hollister SJ, Krebsbach PH (2007). Localized viral vector delivery to enhance in situ regenerative gene therapy. Gene Ther 14:891–901.

12.

Hu WW, Lang MW, Krebsbach PH (2008). Development of adenovirus immobilization strategies for in situ gene therapy. J Gene Med 10:1102–1112.

13.

Kaigler D, Wang Z, Horger K, Mooney DJ, Krebsbach PH (2006). VEGF scaffolds enhance angiogenesis and bone regeneration in irradiated osseous defects. J Bone Miner Res 21:735–744.

14.

Khouri RK, Brown DM, Koudsi B, Deune EG, Gilula LA, Cooley BC, et al. (1996). Repair of calvarial defects with flap tissue: role of bone morphogenetic proteins and competent responding tissues. Plast Reconstr Surg 98:103–109.

15.

Koh JT, Zhao Z, Wang Z, Lewis IS, Krebsbach PH, Franceschi RT (2008). Combinatorial gene therapy with BMP2/7 enhances cranial bone regeneration. J Dent Res 87:845–849.

16.

Krebsbach PH, Gu K, Franceschi RT, Rutherford RB (2000). Gene therapy-directed osteogenesis: BMP-7-transduced human fibroblasts form bone in vivo. Hum Gene Ther 11:1201–1210.

17.

Lee JY, Musgrave D, Pelinkovic D, Fukushima K, Cummins J, Usas A, et al. (2001). Effect of bone morphogenetic protein-2-expressing muscle-derived cells on healing of critical-sized bone defects in mice. J Bone Joint Surg-Am 83(A):1032–1039.

18.

Nussenbaum B, Rutherford RB, Teknos TN, Dornfeld KJ, Krebsbach PH (2003). Ex vivo gene therapy for skeletal regeneration in cranial defects compromised by postoperative radiotherapy. Hum Gene Ther 14:1107–1115.

19.

Nussenbaum B, Rutherford RB, Krebsbach PH (2005). Bone regeneration in cranial defects previously treated with radiation. Laryngoscope 115:1170–1177.

20.

Reuther T, Schuster T, Mende U, Kubler A (2003). Osteoradionecrosis of the jaws as a side effect of radiotherapy of head and neck tumour patients—a report of a thirty year retrospective review. Int J Oral Maxillofac Surg 32:289–295.

21.

Würzler KK, DeWeese TL, Sebald W, Reddi AH (1998). Radiation-induced impairment of bone healing can be overcome by recombinant human bone morphogenetic protein-2. J Craniofac Surg 9:131–137.

22.

Yang S, Wei D, Wang D, Phimphilai M, Krebsbach PH, Franceschi RT (2003). In vitro and in vivo synergistic interactions between the Runx2/Cbfa1 transcription factor and bone morphogenetic protein-2 in stimulating osteoblast differentiation. J Bone Miner Res 18: 705–715.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

1.09 MB